CD International Enterprises, Inc. is a U.S.-based company operating in two primary business segments: mineral trading and consulting services. Headquartered in Deerfield Beach, Florida, with operations centering on the rapid growth of the Chinese economy, CDII allows prospective investors to participate in the considerable opportunities presented by emerging markets in both the People's Republic of China and the Americas.

CDII Minerals, Inc., a wholly-owned subsidiary of CD International, serves as its commodities trading division. Through CDII Minerals, CDII sources, aggregates and distributes iron ore, manganese ore and scrap metals for clients operating throughout China. The company maintains a strategic position between its North and South American suppliers and its Chinese clients, allowing it to both address a niche market opportunity and facilitate more efficient transactions for its customers.

In addition to its mineral trading services, CDII has found success in offering a comprehensive suite of consulting services related to the unique characteristics of business operations in China. In December 2016, the company announced its entry into a two-year corporate agreement with a China-based subsidiary of Everbright International Construction Engineering Corporation, through which CDII will provide information related to foreign and domestic constructions, project tending offers, government communications and local networks. In January 2017, CDII announced its entry into a similar agreement with Zhangjiajie Shengshi Agricultural Development Company, through which it will provide consulting services related to a number of business developments, including the development of a distribution business centered on cannabidiol extract derived from industrial hemp.

Per the company's website, CDII's greatest strength lies in the quality of its personnel, which includes a culturally diverse group of professionals operating within the United States, as well as in China and emerging markets throughout the Americas. Dr. James Wang has served as CEO and chairman of the CDII board since August 2006. He has also served as CEO and chairman of China Direct Investments since January 2005. Wang brings a wealth of experience in corporate finance in the U.S. capital markets to the CDII management team, and his work in the identification and acquisition of China-based growth companies has played an instrumental role in the execution of CD International's strategic vision for over a decade.

Wang is joined on the CDII management team by Controller Shirley Xu and Vice President of Business Development Katie Zhao. Xu has served as the company's controller since January 2013, assuming a range of responsibilities including internal control, general ledger accounting oversight, and financial reporting for CDII and its subsidiaries. She is also responsible for SEC financial reporting for the company's consulting segment clients.

Katie Zhao has served in her current role with CD International since January 2012. Prior to becoming VP of business development, she served as the company's project manager from 2007 to 2009 and as senior account executive from 2010 to 2011. From these positions, Zhao played a key role in the establishment of CDII's U.S. distribution channels for its Chinese clients, as well as the implementation of a network connecting the company's U.S. and China-based offices.

CD International Enterprises, Inc. (OTC: CDII), a U.S.-based company that sources industrial commodities and provides business and management corporate consulting services, this morning announced the launch of wholly-owned subsidiary Green Products Distribution, Inc. and its associated online store (http://www.greencbdproducts.com/cbd). The announcement comes as part of CDII’s ongoing expansion initiative, which centers on the bulk distribution of cannabidiol (CBD) crystal in the U.S. and the sale of a collection of CBD-based products in various Chinese-speaking communities located around the globe.

Per this morning’s news release, CDII expects to bring the newly-announced Green Products Distribution online store to fully functioning status within the next several weeks. Following this milestone, the company intends to contract an online marketing firm in an effort to market both the store and its CBD-based products in a number of Chinese-speaking communities, which, combined, represent a global market of more than two billion people. In addition to the continued refinement of the new website, CDII also intends to develop a mobile app in order to facilitate optimal distribution of its CBD-based products through increasingly popular mobile commerce channels.

“We are very excited to begin retailing CBD-based products in Chinese-speaking communities through the newly established subsidiary, while also pursuing opportunities to distribute bulk CBD crystal in the U.S.,” Dr. James Wang, chairman and CEO of CDII, stated in this morning’s news release. “Research has indicated CBD to be effective in treating epilepsy, Alzheimer’s disease, cirrhosis of the liver and to provide relief from hangover, anxiety and stress. Because natural extract of CBD-based products is so similar to traditional Chinese medicine, management believes there is huge opportunity in Chinese-speaking communities for CBD-based products.”

In support of its newly-launched subsidiary, CDII is actively sourcing a variety of CBD-based products in the U.S., with initial plans in place to enter several distribution agreements in the near term. Through these planned agreements, CDII will also look to commercialize its products through retail pharmacies and Chinese medicine stores across Mainland China.

This morning’s update comes less than two weeks after CDII announced its entry into a multi-year distribution agreement with Zhangjianjie Shengshi Agricultural Development Company, Ltd. to distribute high-grade CBD crystal in the United States. According to data published by The Hemp Business Journal, CBD is currently one of the fastest-growing market categories in the U.S. hemp and legal marijuana industries, boasting a compound annual growth rate of roughly 59 percent. The CBD industry accounted for $202 million in consumer sales in 2015, and forecasts call for that figure to grow to about $2.1 billion by 2020.

CD International Enterprises, Inc. (OTC: CDII), a U.S.-based company that sources industrial commodities and provides business and management corporate consulting services, this morning announced the launch of wholly-owned subsidiary Green Products Distribution, Inc. and its associated online store (http://www.greencbdproducts.com/cbd). The announcement comes as part of CDII’s ongoing expansion initiative, which centers on the bulk distribution of cannabidiol (CBD) crystal in the U.S. and the sale of a collection of CBD-based products in various Chinese-speaking communities located around the globe.

Per this morning’s news release, CDII expects to bring the newly-announced Green Products Distribution online store to fully functioning status within the next several weeks. Following this milestone, the company intends to contract an online marketing firm in an effort to market both the store and its CBD-based products in a number of Chinese-speaking communities, which, combined, represent a global market of more than two billion people. In addition to the continued refinement of the new website, CDII also intends to develop a mobile app in order to facilitate optimal distribution of its CBD-based products through increasingly popular mobile commerce channels.

“We are very excited to begin retailing CBD-based products in Chinese-speaking communities through the newly established subsidiary, while also pursuing opportunities to distribute bulk CBD crystal in the U.S.,” Dr. James Wang, chairman and CEO of CDII, stated in this morning’s news release. “Research has indicated CBD to be effective in treating epilepsy, Alzheimer’s disease, cirrhosis of the liver and to provide relief from hangover, anxiety and stress. Because natural extract of CBD-based products is so similar to traditional Chinese medicine, management believes there is huge opportunity in Chinese-speaking communities for CBD-based products.”

In support of its newly-launched subsidiary, CDII is actively sourcing a variety of CBD-based products in the U.S., with initial plans in place to enter several distribution agreements in the near term. Through these planned agreements, CDII will also look to commercialize its products through retail pharmacies and Chinese medicine stores across Mainland China.

This morning’s update comes less than two weeks after CDII announced its entry into a multi-year distribution agreement with Zhangjianjie Shengshi Agricultural Development Company, Ltd. to distribute high-grade CBD crystal in the United States. According to data published by The Hemp Business Journal, CBD is currently one of the fastest-growing market categories in the U.S. hemp and legal marijuana industries, boasting a compound annual growth rate of roughly 59 percent. The CBD industry accounted for $202 million in consumer sales in 2015, and forecasts call for that figure to grow to about $2.1 billion by 2020.

In the West, it has now been accepted that cannabidiol (CBD) has medical benefits, and CBD products are increasingly making their way to market. One of the better known of these is Sativex, a mixture of delta-9-tetrahydrocannabinol (THC) and CBD in an oromucosal spray that has been approved by regulatory authorities in 28 countries, including Australia, Canada, Germany, Italy, Spain, and the U.K.

However, ancient Chinese texts indicate that CBD and other cannabinoids have been employed extensively in traditional Chinese medicine. Now, to bring those ancient cures to Chinese-speaking communities around the world, CD International Enterprises, Inc. (OTC: CDII) is planning to distribute CBD products to this potential global market of over two billion people.

In a press release issued on Tuesday, April 12, CD International Enterprises announced new initiatives to retail and wholesale CBD products. The company has launched a newly-formed, wholly-owned subsidiary, Green Products Distribution, Inc., and a new online store, Green CBD Products, to retail CBD cures to customers in China and to the many Chinese-speaking communities sprinkled throughout the world. In addition, it plans to distribute bulk CBD crystal in the U.S.

There are references in ancient Chinese medical records on the use of cannabinoids to treat epilepsy, seizures, and pain, which are thought to relate mainly to CBD, since the Chinese were well aware that it had no psychoactive effect, unlike THC. Today, research has indicated CBD to be effective in treating epilepsy, Alzheimer’s disease, cirrhosis of the liver, and even to provide relief from hangover, anxiety, and stress.

CD International will spend the next several weeks getting the online store to fully functioning status, after which the company plans to contract an online marketing firm to promote the store and its products to Chinese diasporas. The company also plans to develop an app for optimal distribution of CBD-based products through mobile devices.

CD International is also actively sourcing a variety of CBD-based products in the U.S. and plans to enter several agreements for their distribution in the near term. Related plans include distributing CBD-based products through retail chains of pharmaceutical and Chinese medicine stores in China. These agreements fall under the company’s trading division, which engages in sourcing and distributing industrial commodities such as CBD-related products, oil-related products, mineral ores, and non-ferrous metals.

The company also operates a consulting division, which provides services to public and private American and Chinese entities seeking access to the U.S. and Chinese capital markets. These services include general business consulting, guidance on Chinese regulation, translation services, advice on the formation of entities in the People’s Republic of China (PRC), and advice on mergers and acquisitions, strategic alliances and partnerships. The company also provides advice to Chinese companies seeking access to the U.S. capital markets and compliance with Sarbanes-Oxley, in addition to undertaking corporate asset evaluations.

With a wealth of experience and international distribution networks already in place, CD International Enterprises, Inc. (OTC: CDII) recently formed a new subsidiary and launched a new online store to maximize product delivery and penetrate a market of 2+ billion people.

For over a decade, CD International has sourced and distributed industrial commodities in China and the Americas. Headquartered in South Florida, the company has focused on international commodity sourcing and trading in iron ore, manganese ore, and scrap metals for companies located throughout the People’s Republic of China. To facilitate its commodity trading services, CD International also provides financing, logistics, quality control and legal and technical due diligence to its suppliers and purchasers. The company’s trading division naturally spawned CD International’s consultation services division to provide guidance for Chinese entities to compete in a complex global economy. The company’s background and know-how have given it the unique ability to identify and exploit emerging global market opportunities. In conjunction with its ongoing expansion initiative, CD International recently embarked upon a new enterprise to leverage its international experience and profit from the bulk distribution of medicinal cannabidiol (CBD) products in the U.S. and the sale of CBD-based products to the 2+ billion Chinese-speaking people located around the globe.

With the launch of its wholly-owned subsidiary, Green Products Distribution, and its online retail store (http://www.greencbdproducts.com/cbd), CD International is positioned to capture more than a fair share of this burgeoning market. With a projected annual growth rate north of 50 percent and the innate acceptance of holistic medicinal treatments in the Chinese culture, CD International fully expects this new enterprise to exceed expectations. The company’s expertise in international trade and its understanding of the vagaries of Chinese commerce give the company competitive advantages to exploit and capitalize on this fast developing global market.

A seemingly curious diversion from conventional business practices, the opportunity is just too great for the company not to engage. Chairman and CEO of CD International, Dr. James Wang, recently stated, “Research has indicated CBD to be effective in treating epilepsy, Alzheimer’s disease, cirrhosis of the liver and to provide relief from hangover, anxiety and stress. Because natural extract of CBD-based products is so similar to traditional Chinese medicine, management believes there is huge opportunity in Chinese-speaking communities for CBD-based products.”

Given the company’s track record in international business and its deep understanding of Chinese culture and practices, CD International’s latest foray is far from just a curious diversion.

CD International Enterprises, Inc. (OTC: CDII), a U.S.-based company that sources industrial commodities and provides business and management corporate consulting services, this morning announced its entry into a partnership agent sales agreement with NutraFuels, Inc. (OTC: NTFU), a manufacturer and distributor of naturally-derived, liquid-based health and wellness nutraceutical products. Under the terms of the agreement, CD International will market NutraFuels’ available product lines to the global Chinese-speaking population.

Founded in 2010, NutraFuels currently manufactures a range of nutritional products, including five unique oral spray daily health and wellness products containing industrial hemp-based cannabidiol (CBD). These supplements have been shown to support various daily health and wellness goals, including weight loss, stress relief, improved energy and focus, better sleep and lasting pain relief.

“We are pleased to bring one of the best CBD-based products in the U.S. to the Chinese population,” Dr. James Wang, chairman and CEO of CD International, stated in this morning’s news release. “We believe that NutraFuels’ intra-oral spray delivery system is highly effective and it allows for optimal absorption of CBD into the human body. China has a global consumer base of 2 billion people, representing more than 20% of the world’s total population, and consisting of consumers that predominantly embrace homeopathic and natural remedies. We are confident that the newly emerging CBD market in China represents great potential for our Company and its investor.”

This morning’s update comes just a week after CD International announced the launch of its newly-formed Green Products Distribution, Inc. subsidiary and online store (http://www.greencbdproducts.com/cbd) in line with its ongoing initiative to distribute CBD-based products in Chinese-speaking communities. As part of that update, the company unveiled plans to actively source a variety of CBD-based products in the U.S. through entry into several distribution agreements in the near term, plans which are already taking shape through CD International’s new partnership with NutraFuels.

In addition to distributing these products through its online store, CD International also intends to distribute these high quality CBD-based products through retail chains of pharmaceutical and Chinese medicine stores located in Mainland China. Other active initiatives currently in CD International’s pipeline include the development of a mobile app in order to promote optimal distribution of CBD-based products through increasingly popular mobile channels, as well as distribution of bulk CBD crystal within the rapidly-evolving U.S. market.

CD International Enterprises, Inc. (OTC: CDII), a U.S.-based company that sources industrial commodities and provides business and management corporate consulting services, this morning announced its entry into a wholesale distribution agreement with a U.S.-based manufacturer of cannabidiol-based products. Through this agreement, CDII will purchase cannabidiol (CBD) products at a wholesale price before marketing them to the Chinese-speaking population.

“We are very excited to bring these premium CBD-based products, manufactured in the U.S., to the Chinese-speaking population,” Dr. James Wang, chairman and CEO of CDII, stated in the news release. “As CBD-based products are new in the Chinese market, we believe it is an ideal point in time to bring top-quality product lines to the Chinese market place. We are prepared to be the pioneer that can empower the health conscious Chinese population with top quality premium CBD-based supplements.”

CDII’s new distribution partner currently markets a wide assortment of popular CBD-based products and supplements. Some of the most popular include Chill and Relax Gummies, a tasty selection of more than 200 flavored CBD hemp oils, Blue CBD Crystals Isolate, the Relax Extreme CBD collection, CBD shots and premium vape additives.

This morning’s update comes just a week after CDII announced its entry into a partnership agent sales agreement with NutraFuels, Inc. (OTC: NTFU), a manufacturer, marketer and distributor of naturally-derived liquid-based health and wellness nutraceutical products. Through that partnership, the company gained access to five of NutraFuels’ oral spray daily health and wellness products, which it also intends to market to the Chinese-speaking population. With a global community including more than two billion people, the Chinese-speaking population represents a sizable opportunity for CDII as the CBD market continues to gain steam both in China and around the world.

Data published by The Hemp Business Journal notes that CBD and related products represent one the fastest-growing market categories in the hemp and legal marijuana industries, achieving a compound annual growth rate of 59 percent in the U.S. In 2015, the CBD industry was valued at roughly $202 million, and it is expected to grow to $2.1 billion in consumer sales by 2020. With this performance in mind, CDII is actively sourcing a variety of CBD-based products in the U.S., with plans to enter into additional distribution agreements in the near term. The company intends to distribute these products through both its newly-launched online store (http://www.greencbdproducts.com/cbd) and retail chains of pharmaceutical and Chinese medicine stores in Mainland China.

CD International Enterprises, Inc. (CDII) is Helping to Balance Payments between the US and China

One of the most puzzling aspects of the debate on U.S. trade with China is the absence of any reference to the balance of payments. The focus has been and continues to be on the current and trading accounts and the U.S. deficits on those accounts. Firstly, it is unclear why we should be worried that China is willing to accept entries in a ledger in exchange for tangible goods. Secondly, the focus on merchandise trade and services means not seeing the forest for the trees. The trade deficit must be balanced by a surplus in other balance of payment accounts. For every Chinese widget an American consumer buys, China gets U.S. dollars, most of which find their way into U.S. Treasuries, but they are increasingly finding their way into other asset classes. Facilitating that process and assisting Chinese companies to invest directly in the U.S. is CD International Enterprises, Inc. (OTC: CDII), a U.S.-based company that sources industrial commodities and provides business and management corporate consulting services.

The current account, which includes the merchandise trade account, is just one of three major accounts that make up the overall balance of payments, so called because it is an accounting device, which, like a balance sheet, is meant to balance. Apart from the current account, the balance of payments includes the capital account and the financial account. Transactions in the current account are offset by balancing transactions in either the capital account or financial account. This means that Americans are buying Chinese goods on current account, while Chinese are buying American assets on the capital and financial accounts.

Those dollars leaving American shores have been finding their way back. Earlier this year, the Financial Times reported a surge in Chinese corporate investment into the U.S. (http://dtn.fm/rS1M6), writing that ‘Chinese companies invested a record $45.6 billion in the U.S. in 2016’. This was three times as much as the Chinese direct investment in 2015. Now, China’s long-term investment in U.S. physical assets exceeds $100 billion for the first time, taking employment by Chinese-owned U.S. companies to about 100,000.

CD International Enterprises is part of that direct investment nexus. The company is geared to provide advice to Chinese entities on the U.S. capital markets, cross-border transactions, Sino-American joint venture structure, foreign invested entity structure, mergers and acquisitions and divestitures. CD International will also undertake screening and due diligence of potential acquisition targets for Chinese corporate buyers.

The consulting services it offers comprise just one division of CD International. The company also trades commodities through its wholly owned subsidiary CDII Minerals, Inc., which sources, aggregates, and distributes iron ore, manganese ore, and scrap metal for companies in the People’s Republic of China.

In April, CD International announced the launch of its newly formed, wholly owned subsidiary, Green Products Distribution, Inc., and the associated online store Green CBD Products (http://dtn.fm/rr8kC), aimed at the Chinese-speaking diaspora.

The launch of Green Products Distribution and the associated online store is a key part of the company’s expansion plans. With this launch, CD International’s chief objective is to retail CBD-based products to Chinese-speaking communities, which collectively represent a global market of over two billion people. After getting the online store up and running within the next several weeks, the company plans to contract an online marketing firm to promote the online store and its products in Chinese-speaking communities across the world. Other plans under consideration by CD International include developing a mobile app for optimal distribution of CBD-based products through mobile devices and the bulk distribution of cannabidiol (CBD) crystal in the U.S.

The company has also entered into a partnership agent sales agreement with NutraFuels, Inc. (OTC: NTFU), a manufacturer and distributor of naturally derived, liquid-based health and wellness nutraceutical products. Under the terms of the agreement, CD International will market NutraFuels’ available product lines to the global Chinese-speaking population. These include five unique oral spray daily health and wellness products containing industrial hemp-based CBD. These supplements have been shown to support various daily health and wellness goals, including weight loss, stress relief, improved energy and focus, better sleep and lasting pain relief.

CD International Enterprises, Inc. (OTC: CDII), a U.S.-based company that sources industrial commodities and provides business and management corporate consulting services, this morning announced its entry into a letter of intent with a Honduras-based company to purchase iron ore (62% to 63% Fe). Per the terms of the agreement, CDII agrees to purchase 100,000 metric tons of iron ore per month over a 12-month period, equating to a total shipment of 1.2 million metric tons over the life of the agreement. The initial 12-month contract values approximately $84 million on basis of the current CIF China price, and the deal also includes an option to increase monthly supply to 500,000 metric tons per month.

“We are pleased to enter this letter of intent, as we have been proactively sourcing iron ore supply for our Chinese clients,” Dr. James Wang, chairman and CEO of CD International, noted in this morning’s news release. “This newly sourced supply could provide us a stable supply of iron ore for our clients in China. Under our new mineral trading model, we believe we can create a profit center while we limit exposure of our capital to market risk. Imported iron ore to China will continue at the levels we are seeing now, or perhaps even grow as we go forward. We actively pursue new mineral suppliers for our clients in China in both South and North America. As we move forward, we believe we are well positioned to take advantage of increasing demand of iron ore by China in years to come.”

This morning’s update comes as Chinese customs data suggests rising demand for iron ore. Per the news release, China’s imports of iron ore rose 7.5 percent in 2016 to a record of 1.024 billion tons. Continuing this trend, China’s March 2017 iron ore imports were up 11 percent year-over-year to 95.56 million tons, according to data from the General Administration of Customs, marking the second-highest monthly total on record.

CDII’s latest update follows a series of moves designed to capitalize on the forecast growth of the cannabidiol (CBD) market. Last month, the company announced the launch of Green Products Distribution Inc., a wholly-owned subsidiary focused on the sale of CBD-based products in Chinese-speaking communities.

CD International Enterprises, Inc. (CDII) Leveraging Experience and Relationships to Capitalize on Opportunity

For over a decade, multi-faceted CD International Enterprises, Inc. (OTC: CDII) has successfully sourced and distributed industrial commodities such as iron ore, manganese ore, and scrap metals for delivery to businesses in the People’s Republic of China. In fact, the company recently announced that it has entered into a letter of intent with a Honduras-based company to purchase 1.2 million metric tons of iron ore over a 12-month period (http://dtn.fm/yOQ70). The initial 12-month contract of 1.2 million metric tons of iron ore values at approximately $84 million on basis of the current CIF China price. In addition, the monthly supply can be increased to 500,000 metric tons per month, or six million metric tons of iron ore per year.

Leveraging commodities sourcing as a liaison between three continents, CD International has established strong relationships in South America, North America and Asia. These relationships have provided the company opportunities to expand its business services to suppliers and purchasers to include financing, logistics, quality control and legal due diligence, as well as providing consultation services and guidance for Chinese entities to compete in a complex global economy. The company’s wide-ranging services made it a one-stop-shop for international companies looking to leverage global market opportunities.

Always on the lookout for exceptional global market opportunities itself, CD International recently undertook a new enterprise and formed a new division to profit from one of the fastest-growing market categories in the world. The company formed its Green Products division and online retail store (http://www.greencbdproducts.com/cbd) to distribute and sell medicinal cannabidiol (CBD) based products to the 2+ billion Chinese-speaking people located around the globe. Non-euphoric CBD-based products have a broad range of therapeutic uses, including treating epilepsy, anxiety, pain and nausea. CBD oil is legal in all 50 U.S. states and can be exported to over 40 countries including China, and CBD-based products have a projected 60 percent annual growth rate.

The company’s extensive international experience and relationships have given it a unique ability to identify and capitalize on emerging global market opportunities. The company has an abundant knowledge of the innate practices of the Chinese consumer and Chinese commerce, which gives it competitive advantages in this fast-developing global market. CBD-based products fit well with traditional Chinese holistic medicine, and the company believes the demand in Chinese-speaking communities for CBD-based products will exceed expectations.

CD International’s wealth of international experience and extensive understanding of the workings of Chinese commerce and culture make it an interesting cross market opportunity in both the medical marijuana and Chinese consumer arenas.

CD International Enterprises, Inc. (OTC: CDII), a U.S.-based company that sources industrial commodities and provides business and management corporate consulting services, this morning announced its entry into a full corporate offer to purchase 5,000 tons of copper cathodes (99.99% Cu) per month from a company based in Tanzania. “We are very excited to enter this full corporate offer as our Chinese clients are ready to make purchases,” Dr. James Wang, chairman and CEO of CDII, stated in the news release. “To fulfill a niche market and facilitate smooth transactions, we have been working very hard in the past several years to strategically place ourselves between our suppliers and our buyers in China… We expect to commence the first shipment for our clients within months.” Per the terms of the offer, CDII will be required to purchase 5,000 metric tons of copper cathodes per month over an initial period of 12 months, leading to a total annual shipment of 60,000 metric tons. Based on current copper future prices pulled from the London Metal Exchange, this contract total of 60,000 metric tons is valued at approximately $330 million.

CD International Enterprises, Inc. (CDII) Positioned to Profit from CBD

Since 2001, CD International Enterprises, Inc. (OTC: CDII) has been building international business relationships. This diverse U.S.-based company has nurtured multiple global business relationships to more effectively source and deliver various industrial commodities to its clients in the People’s Republic of China. CD International is a transactional intermediary, locating and securing commodities such as iron ore, manganese ore, copper and scrap metals from around the globe to feed the industrial needs of its China-based business clients.

On Wednesday, CD International announced its entry into a full corporate offer to purchase 5,000 tons of copper cathodes (99.99% Cu) per month from a company based in Tanzania. Dr. James Wang, chairman and CEO of CDII, stated in the news release, “We are very excited to enter this full corporate offer as our Chinese clients are ready to make purchases. To fulfill a niche market and facilitate smooth transactions, we have been working very hard in the past several years to strategically place ourselves between our suppliers and our buyers in China.” CDII will purchase 5,000 metric tons of copper cathodes per month over an initial period of 12 months, equating a total annual shipment of 60,000 metric tons. Based on current copper prices, this contract for 60,000 metric tons is valued at approximately $330 million. Simply put, CDII locates and negotiates for the commodities its buyers’ need.

Utilizing commodities sourcing as a global liaison, CD International has established strong worldwide business relationships. These relationships have provided the company opportunities to expand its business services to suppliers and purchasers to include financing, logistics and quality control, as well as provide consultation services and guidance for Chinese entities to compete in a complex global economy. The company’s success in multiple cross-border transactions shows that it has the unique ability to identify emerging market opportunities and provide comprehensive solutions to effectively conduct international business.

With an impressive track record of global transactions, CD International just launched a new division to distribute cannabidiol-based (CBD) products to the global Chinese speaking population. The launch of its Green Products Distribution Division (http://dtn.fm/fEh09) and the online store (http://www.greencbdproducts.com/cbd) are key components of the company’s expansion plans, with a primary focus to retail CBD-based products in Chinese-speaking communities, which collectively represent a potential global market of over two billion people. Non-euphoric CBD-based products have a broad range of therapeutic uses including treatment for epilepsy, anxiety, pain and nausea.

With multiple successful global transactions, a wealth of international relationships and in-depth knowledge of the innate practices of Chinese commerce, CD International is positioning to profit from the 60 percent annual growth rate of CBD-based products.

CD International Enterprises, Inc. (OTC: CDII), a U.S.-based company that sources industrial commodities and provides business and management corporate consulting services, this morning announced its entry into a wholesale distribution agreement with GWR Distributors, Inc., one of the world’s leading suppliers of cannabidiol-based products derived from hemp. Per the terms of the agreement, CDII will purchase CBD products at a wholesale price from GWR Distributors, including CBD capsules and concentrates, edibles and oils, isolates, syrup and terp and CBD for pets, which it will then market to a global community of more than 1.6 billion Chinese-speaking consumers. “We are very pleased to work with GWR Distributors, one of the world’s leading suppliers of CBD-based products, to bring the best CBD-based products manufactured in the U.S. to our target market,” Dr. James Wang, chairman and CEO of CDII, stated in the news release. “With multiple successful global transactions, a wealth of international relationships, and in-depth knowledge of the innate practices of Chinese commerce and customers, we believe we are well-positioned to take advantage of substantial growth of CBD based products in China for years to come.”

A specialist in the industrial commodities and corporate consulting services sector, CD International Enterprises, Inc. (OTC: CDII) now has access to a global market representing more than two billion prospective customers. The company has been expanding into the cannabidiol (CBD) market and recently launched a wholly-owned subsidiary and online store. Targeting Chinese-speaking communities in the U.S. and around the world, it has also been reaching into the mobile web with the ongoing development of an app to distribute CBD products through mobile devices.

The company launched its online store (http://greencbdproducts.com/cbd) this year, as well as its Green Products Distribution, Inc. subsidiary. These initiatives represent a major component of CD International’s expansion plans. As the online store reaches full functionality, products will be added to the catalog, where a secure online ordering system will enable customers to purchase the highest quality CBD oil and other products.

A contract with an online marketing firm is expected to help expand the reach of the store and its product line. On the sourcing front, the company is planning several distribution agreements with U.S. firms, in addition to its plans to work with pharmaceutical and Chinese Medicine retailers in China. Also, a recent agreement signed with GWR Distributors now means access to wholesale-priced CBD capsules, concentrates, edibles, oils, syrups, and more. This boosts the potential of the online store now in development.

The store will sell over 200 different flavored CBD hemp oils. Vape additives will be available as well. Not psychoactive like tetrahydrocannabinol (THC), CBD has been shown to benefit people with numerous diseases. In clinical studies, it has been found to be effective as a treatment for epilepsy, anxiety, inflammation, neurodegenerative diseases, and autoimmune diseases and to be a powerful antioxidant. The products sourced in the U.S. are produced to high quality standards and are in compliance with ISO 6 clean room standards. The process used yields 99 percent pure CBD isolate.

Reaching $202 million by 2015, the global cannabidiol market represents the fastest growing segment of the marijuana industry, according to a Consilium Global Research report (http://dtn.fm/ZXh2t). It is expected to reach $2.1 billion in consumer sales by 2020. Given the fluidity of U.S. and international law related to medical marijuana, CD International continues to look for new market opportunities amongst the Chinese-speaking population in the United States and abroad. Its global experience with sourcing/selling iron ore, manganese ore, and scrap metals and providing financing and logistics services positions the company to move forward in the CBD market.

“It is an exciting time to source and market CBD-based products. Around the world, the Chinese population remains health conscious, and the health benefits of CBD oils and other products mean these high-quality commodities are in high demand. We’re proud to source our products in the U.S. and have the capacity to distribute them to anywhere in the world,” Dr. James Wang, chairman and CEO of CD International Enterprises, stated in a news release.

Learn more about the Company, its subsidiary, mineral trading and consulting divisions, and growing online CBD products store by going to http://www.cdii.net.

CD International Enterprises, Inc. (OTC: CDII), a U.S.-based company that sources industrial commodities and provides business and management corporate consulting services, this morning announced its entry into a full corporate offer with a Dominican Republic-based company for the monthly purchase of 100,000 tons of metallurgical-grade bauxite. Per the terms of the offer, CDII will be required to purchase 100,000 metric tons of bauxite per month for an initial period of 12 months, equating to a total shipment of 1.2 million metric tons. This contract is valued at approximately $37 million based on current FOB prices at Cabo Rojo, Dominican Republic. “We are pleased to enter into this agreement on the heels of signing a separate offer to purchase copper cathodes, valued at approximately $330 million,” Dr. James Wang, chairman and CEO of CDII, stated in the news release. “As part of sourcing a variety of industrial commodities for our clients in China, we are advancing our newly established business model and leveraging our existing connections in China. Upon a successful delivery of bauxite to our clients in China, we believe we will enter a new level of business.”

In a landmark new study, The New England Journal of Medicine just confirmed what thousands have attested to anecdotally for years (http://dtn.fm/zTW93). Cannabidiol, which is found in marijuana plants, dramatically reduces the number of convulsive seizures in children with a severe and often fatal epilepsy disorder. Dravet syndrome is a rare, genetic form of epilepsy diagnosed when otherwise healthy infants start having unexplained seizures. The syndrome is a complex childhood drug-resistant disorder with uncontrollable seizures and a high mortality rate. Recurrent grand mal seizures, sometimes dozens even hundreds a month, literally take over and convulse the entire body. Most patients don’t live to reach adulthood and of those who do, most are unable to live independently.

The results of this latest study follow a sweeping 400-page report released in January by the National Academies of Science, Engineering, and Medicine which covered more than 10,000 scientific studies on marijuana and medicine. The far reaching report reached multiple conclusions, among those, the firm verification that marijuana does have legitimate medical uses. The report’s resulting conclusions are supported by high-quality scientific studies that show cannabis and cannabinoids are effective at treating chronic pain, particularly pain related to multiple-sclerosis, also, that cannabinoid substances were effective for treating chemotherapy-related nausea and vomiting in cancer patients.

Cannabidiol, also called CBD, is one of more than 80 active cannabinoid chemicals in the marijuana plant, which unfortunately is classified as a Schedule I controlled substance by the federal government. Unlike tetrahydrocannabinol, or THC, CBD does not produce euphoria or a high, and multiple states have legalized its medicinal use. Anecdotal no more, two major studies released in the last four months have scientifically validated the efficacy of medicinal marijuana. To hear some tell it, the flood gates of hell have opened to allow this scourge of a drug credibility in this country. Those who suffer give thanks for access to their medicine.

With medical efficacy questions put to bed, smart money is now looking for avenues to profit from this explosive new medical market. With a projected 60 percent annual growth rate in the U.S. alone, it makes sense to look globally and to population density for an even stronger strategic play.

CD International Enterprises, Inc. (OTC: CDII), a diverse U.S.-based company with multiple global business relationships, has effectively sourced and delivered various industrial commodities to its clients in the People’s Republic of China for over 15 years. CDII’s extensive international experience and relationships give it the uncommon ability to identify and capitalize on emerging global market opportunities. The company recently formed a new division to distribute and sell medicinal CBD-based products to the 2+ billion Chinese-speaking people located around the globe. More than two billion people is one heck of a target market, and CDII has abundant knowledge of the innate practices of the Chinese consumer and Chinese commerce, which gives it competitive advantages in this fast developing global industry.

The company has already formed its new Green Products division and online retail store for CBD-based products (http://www.greencbdproducts.com/cbd). CBD oil is legal in China, and CBD-based products fit well with traditional Chinese holistic medicine. CDII believes the demand in Chinese-speaking communities for CBD-based products will easily exceed expectations. Looks like science has turned anecdotal evidence into opportunity.

Learn more about the company, its subsidiary, mineral trading and consulting divisions, and growing online CBD products store by going to http://www.cdii.net.

CD International Enterprises, Inc. (OTC: CDII) is a company based in the United States that is engaged in sourcing industrial commodities and providing business and management corporate consulting services. CD International is once again leveraging the strength of its plentiful global contacts and applying its expertise to take advantage of new opportunities — this time in the burgeoning cannabis industry.

The cannabis market has been projected to reach $2.1 billion by the year 2020 (http://dtn.fm/PTuL0). Within the blossoming legal marijuana and hemp industries, cannabidiol (CBD) — a cannabinoid compound that does not cause psychoactive effects — is one of the most rapidly growing segments, having gone from almost nothing to an impressive $202 million by 2015 and increasing at a reported CAGR of 80 percent.

CD International offers a full suite of consulting services that are tailored to meet the needs of each of its clients, and a significant aspect of the company’s competitive advantage is its high-quality personnel. Members of the CD International team have a working knowledge of the distinctive attributes of business operations in China, and the company utilizes this expertise to provide needful resources to enable Chinese entities to compete effectively in the global economy. This facet of CD International’s business operations is lending itself well to the company’s new foray into the cannabis market.

Earlier this year, CD International launched a brand-new division that is focused on distributing CBD crystal in the United States and providing CBD-based products to the Chinese-speaking population (http://dtn.fm/3EAwP). The launch of the company’s Green Products Distribution division and its associated online store is an integral component of CD International’s expansion plans. With this launch, the company’s main aim is retailing CBD-based products in Chinese-speaking communities — a group that collectively comprises a worldwide market of more than two billion.

CBD products have demonstrated efficacy in relieving pain and inflammation and may also be effective in treating certain neurological disorders. The vast Chinese population CD International serves represents a significant addressable audience for CBD-based products, and CD International’s Green Products Distribution division and online store will specialize in selling non-euphoric CBD products at retail to a global population of Chinese-speaking individuals. The company has recently entered into a wholesale distribution agreement with a CBD-based products manufacturer in the U.S. and plans to purchase products at wholesale and then market them to the Chinese-speaking population.

This new venture marries well with CD International’s existing business dealings and uniquely positions the company to become a brand leader, filling a void within the CBD segment.

Learn more about the company, its subsidiary, mineral trading and consulting divisions, and growing online CBD products store by going to http://www.cdii.net.

What’s the connection, you may ask, between copper and cannabidiol (CBD) crystal, both of which are in the offing to be marketed by CD International Enterprises, Inc. (OTC: CDII). The Florida-based corporation recently signed contracts with suppliers of those commodities and other minerals and plans to target markets in the U.S. and within Chinese-speaking communities around the globe. The nexus in this web of distribution is the company’s logistical savvy. After a decade of shipping a variety of industrial materials around the world, CD International Enterprises knows more than a thing or two about procurement and distribution.

CDII cut its teeth in global distribution when it began sourcing iron ore and other minerals in South America for customers in China. The company established offices in Bolivia, Chile and Peru, and, by 2014, it was shipping copper concentrate from Chile and Bolivia to China. It also established a reputation as a reliable supplier of high-grade magnesium and was, at one time, operating four magnesium facilities with combined production capacity of approximately 32,000 metric tons of pure magnesium. However, the downturn in the minerals market forced a shift in strategy, with CDII applying its logistics know-how in metals to other commodities. Now, with cannabidiol-based products entering the medical mainstream, the company plans to become a major supplier of bulk CBD crystal in the U.S.

In March 2017, the company announced its entry into a multi-year distribution agreement with Zhangjianjie Shengshi Agricultural Development Company (Shengshi) for the distribution of high-grade CBD crystal in the United States. Under the deal, Shengshi will be responsible for large-scale production of CBD, which it processes from industrial hemp grown in China. From this output, up to 100 kilograms per month, or 1,200 kilograms per year, will be provided to CDII for U.S. distribution, with CDII maintaining exclusive U.S. distribution rights for an initial period of 10 years.

In April 2017, CDII signed a wholesale distribution agreement with a U.S.-based manufacturer of cannabidiol-based products. Through this agreement, CDII will purchase CBD products at a wholesale price before marketing them to the Chinese-speaking population. CDII’s new distribution partner currently markets a wide assortment of popular CBD-based products and supplements. Some popular products include Chill and Relax Gummies, a tasty selection of more than 200 flavored CBD hemp oils, Blue CBD Crystals Isolate, the Relax Extreme CBD collection, CBD shots and premium vape additives.

In May 2017, CDII announced its entry into a wholesale distribution agreement with GWR Distributors, Inc., one of the world’s leading suppliers of cannabidiol-based products derived from hemp. Under the agreement, CDII will purchase CBD capsules and concentrates, edibles and oils, isolates, syrup and terpenes and CBD for pets.

CDII hasn’t forgotten its roots, though. The company still trades in mineral ores and has struck a number of deals in recent times. In May 2017, the company announced its entry into a letter of intent with a Honduras-based company to purchase iron ore (62% to 63% Fe). Under the agreement, CDII agrees to purchase 100,000 metric tons of iron ore per month over a 12-month period, equating to a total shipment of 1.2 million metric tons over the life of the agreement. The deal, worth an estimated $84 million at current CIF China prices, also includes an option to increase monthly supply to 500,000 metric tons per month.

Also in May 2017, CDII announced its entry into a full corporate offer to purchase 5,000 tons of copper cathodes (99.99% Cu) per month from a company based in Tanzania. The contract requires CDII to purchase 5,000 metric tons of copper cathodes per month over an initial period of 12 months, leading to a total annual shipment of 60,000 metric tons. Based on London Metal Exchange (LME) futures prices, the contract of 60,000 metric tons is valued at approximately $330 million.

Soon after CDII announced its entry into a full corporate offer with a Dominican Republic-based company for the monthly purchase of 100,000 tons of metallurgical-grade bauxite. The agreement requires CDII to purchase 100,000 metric tons of bauxite per month for an initial period of 12 months, equating to a total shipment of 1.2 million metric tons. This contract is valued at approximately $37 million based on current FOB prices at Cabo Rojo, Dominican Republic.

Learn more about the company, its subsidiary, mineral trading and consulting divisions, and growing online CBD products store by going to http://www.cdii.net.

Diverse Leadership Team Guides Continued Success of CD International Enterprises (CDII)

CD International Enterprises, Inc. (OTC: CDII) is a United States-based company engaged in sourcing and distributing industrial commodities in China and the Americas, as well as providing international business and consulting services. The company’s solutions promote growth and the ability to successfully compete on a worldwide scale, and CD International Enterprises itself serves as a vehicle through which investors can take part directly in the explosive growth of emerging markets in China and the Americas. The company’s success is driven by a culturally diverse team of professionals.

The strength of CD International Enterprises lies in its staff of experts, who collectively boast impressive knowledge regarding the inherent practices of Chinese commerce and combine this with their experience in the U.S. and the Americas. This provides clients an exciting advantage for capitalizing on the growth of the Chinese economy and other emerging markets like Peru, Chile, Bolivia and Ecuador.

CD International Enterprises is uniquely skilled in identifying emerging market opportunities and providing comprehensive solutions and services that are relevant to conducting business internationally. The company operates chiefly within two business segments — trading and consulting services — and recently also launched a new division to distribute cannabidiol (CBD) crystal in the United States and CBD-based products to Chinese-speaking communities.

CD International Enterprises’ culturally diverse team has an advantageous edge in producing global commerce opportunities, and the company’s management team seeks to help its customers navigate cultural and legal challenges that are often confusing. Through the collaborative efforts of its multicultural team members, who work through offices in the U.S., Shanghai and various South American locations, CD International Enterprises offers a number of advantages that are key to success in international business.

The company is helmed by CEO and Chairman Dr. James Wang, Ph.D., who is a cofounder of China Direct Investments and has presided as its CEO and chairman of the board since 2005. He has also been an influential figure within the board rooms and management divisions of various other companies, including CIIC Investment Banking Services (Shanghai) Company, Limited; Genesis Pharmaceuticals, Inc.; China Net & Technologies, Inc.; and Ten Sleep Corporation and its wholly owned subsidiary Master Financial Group. Wang additionally worked as a research scientist, assistant professor and lab director at the University of Minnesota School of Medicine. He earned his Bachelor of Science degree from the University of Science and Technology of China, his Master of Science degree from Shanghai Second Medical University, and his Ph.D. from the University of Arizona.

Shirley Xu has served as CD International Enterprises’ controller since 2013 and oversees all internal control, including general ledger accounting, monthly-end closing, taxation, banking, consolidation, and financial reporting over all of the company’s subsidiaries. She is additionally responsible for SEC financial reporting for clients of the company’s consulting segment. Before joining CD International Enterprises, Xu served as an accountant with Dayton Granger Inc. in Florida and as a financial consultant with ING Group in Hong Kong. She earned her BA degree in accounting from Ramapo College in New Jersey and her BS in engineering from Tongji University in China.

Katie Zhao, MBA, serves CD International Enterprises as its vice president of business development, overseeing corporate development, leading due diligence for mergers and acquisitions, and overseeing internal operations at the company’s U.S. headquarters in Florida. Zhao obtained her master’s degree in business administration from Florida Atlantic University.

CD International Enterprises’ culturally diverse leaders and team members continue to lead the company’s success, providing clients with creative solutions for accessing opportunities in the burgeoning global economy.

Learn more about the company, its subsidiary, mineral trading and consulting divisions, and growing online CBD products store by going to http://www.cdii.net.

- Global medical marijuana sales to grow over 17 percent annually to more than $55 billion by 2025- CDII one of first companies to market CBD to Chinese consumers- CDII has extensive business relationships in China – knows Chinese commerce and consumer- Led by Dr. James Wang – over a decade of success with Chinese businesses

With more than a decade of experience internationally sourcing and distributing industrial commodities such as iron ore, manganese ore, and scrap metals for delivery to businesses in the People’s Republic of China, CD International Enterprises (OTC: CDII) has developed extensive global relationships which have given the company the uncommon ability to identify and capitalize on emerging market opportunities.

Under the leadership of Dr. James Wang, chairman and CEO, CD International has demonstrated repeated success at navigating complex logistical and legal issues to globally source and deliver industrial commodities while maintaining margins and keeping both buyers and sellers of commodities satisfied. Last month alone, the Florida-based company announced full corporate offers to purchase commodities valued in excess of $350 million at current market prices. With a brash, bold initiative, CDII is now expanding into new lucrative territory.

The company’s long success and vision are in no small part attributable to Wang’s comprehensive background and leadership. Wang earned bachelor’s and master of science degrees in China before earning his Ph.D. from the University of Arizona in 1994. He started his career as a research scientist and assistant professor at the University of Minnesota School of Medicine. With a passion and acumen for business, Wang left science, gained vast experience and achieved success at several companies. He has led CD International since its inception in 2006.

With a keen eye for exceptional global market opportunities, Wang and his team have expanded CDII into one of the fastest growing markets in the world, medical marijuana. Global medical marijuana sales are projected to grow at a compound annual growth rate of over 17 percent to more than $55 billion by 2025. To facilitate such a bold initiative and become one of the first to distribute and sell medicinal cannabidiol (CBD) based products to a global population of two billion-plus Chinese-speaking people, the company recently formed its Green Products division and online retail store (http://www.greencbdproducts.com/cbd). Non-euphoric CBD-based products have a broad range of clinically proven therapeutic uses, including treating epilepsy, anxiety, pain and nausea. CBD oil is legal in 29 U.S. states and can be exported to over 40 countries, including China.

Wang and his team have extensive, long established business relationships in China as well as expansive knowledge of the innate practices of the Chinese consumer and Chinese commerce. This gives CD International real competitive advantages in a fast-developing global market. Given the bold vision and history of success of Wang and his team at CDII, it’s hard to believe they won’t exceed expectations again.

Learn more about the company, its subsidiary, mineral trading and consulting divisions, and growing online CBD products store by going to http://www.cdii.net.